dapsone has been researched along with Dermatitis Exfoliativa in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapsone hypersensitivity syndrome (DHS) is a potentially life-threatening adverse drug reaction consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 7.75 | Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. ( Chu, CY; Sheen, YS; Tsai, TF; Wang, SH, 2009) |
| "Dapsone therapy was initiated on day +28 at a dose of 100 mg/day for PCP prophylaxis secondary to the patient's history of a sulfonamide allergy." | 5.33 | The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation. ( Abidi, MH; Ibrahim, RB; Kozlowski, JR; Peres, E, 2006) |
| "Dapsone hypersensitivity syndrome (DHS) is a potentially life-threatening adverse drug reaction consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 3.75 | Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. ( Chu, CY; Sheen, YS; Tsai, TF; Wang, SH, 2009) |
| "Exfoliative dermatitis associated with hepatitis has been reported in leprosy patients taking dapsone in daily dosage of 200 mg daily or more previously." | 3.66 | Sulphone induced exfoliative dermatitis and hepatitis. ( Garg, BR; Lal, S, 1980) |
| "Dapsone therapy was initiated on day +28 at a dose of 100 mg/day for PCP prophylaxis secondary to the patient's history of a sulfonamide allergy." | 1.33 | The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation. ( Abidi, MH; Ibrahim, RB; Kozlowski, JR; Peres, E, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheen, YS | 1 |
| Chu, CY | 1 |
| Wang, SH | 1 |
| Tsai, TF | 1 |
| Abidi, MH | 1 |
| Kozlowski, JR | 1 |
| Ibrahim, RB | 1 |
| Peres, E | 1 |
| Weidner, F | 1 |
| Kötteritz, H | 1 |
| Lal, S | 1 |
| Garg, BR | 1 |
| Patki, AH | 1 |
| Mehta, JM | 1 |
| Smith, WC | 1 |
6 other studies available for dapsone and Dermatitis Exfoliativa
| Article | Year |
|---|---|
Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Chemical and Drug Induced Liver Injur | 2009 |
The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation.
Topics: Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Dapsone; Dermatitis, Exfoliative; Drug Hy | 2006 |
[Erythromelanoderma in pemphigus herpetiformis associated with eosinophilic spongiosis].
Topics: Dapsone; Dermatitis, Exfoliative; Eosinophilia; Female; Humans; Melanosis; Middle Aged; Pemphigus; S | 1980 |
Sulphone induced exfoliative dermatitis and hepatitis.
Topics: Adrenal Cortex Hormones; Adult; Chemical and Drug Induced Liver Injury; Dapsone; Dermatitis, Exfolia | 1980 |
Dapsone-induced erythroderma with Beau's lines.
Topics: Adult; Dapsone; Dermatitis, Exfoliative; Female; Humans; Leprosy, Lepromatous; Nails, Malformed | 1989 |
Hypersensitivity reaction to dapsone.
Topics: Adult; Dapsone; Dermatitis, Exfoliative; Drug Hypersensitivity; Humans; Leprosy; Male; Registries | 1986 |